Page last updated: 2024-08-25

bexarotene and transforming growth factor alpha

bexarotene has been researched along with transforming growth factor alpha in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drenning, SD; Grandis, JR; Hwang, JD; Lamph, WW; Lango, MN; Song, JI; Zeng, Q1

Other Studies

1 other study(ies) available for bexarotene and transforming growth factor alpha

ArticleYear
Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Cancer research, 2001, Aug-01, Volume: 61, Issue:15

    Topics: Animals; Anticarcinogenic Agents; Bexarotene; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Division; DNA-Binding Proteins; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Receptors, Retinoic Acid; Retinoid X Receptors; Signal Transduction; STAT3 Transcription Factor; Tetrahydronaphthalenes; Trans-Activators; Transcription Factors; Transforming Growth Factor alpha; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2001